Monday June 26th 2017

Archive for July, 2015

Immunoregulation of multiple sclerosis by gut environmental factors

Immunoregulation of multiple sclerosis by gut environmental factors

Abstract Microbiota exist symbiotically in the human gut to aid the digestion of nutrients. However, gut microbiota also have immunoregulatory properties. The hygiene hypothesis describes the idea that environmental factors, such as diet, pollution, antibiotic use, vitamin [Read More]

Explaining, not just predicting, drives interest in personal genomics

Explaining, not just predicting, drives interest in personal genomics

Conclusions PGT customers are particularly interested in genetic markers for their existing medical conditions, suggesting that the value of genetic testing is not only predictive, but also explanatory. (Source: Genome Medicine) [Read More]

HU‐446 and HU‐465, derivatives of the non‐psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells

HU‐446 and HU‐465, derivatives of the non‐psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells

This article is protected by copyright. All rights reserved. The study describes the synthesis and the anti‐inflammatory activities of two isomeric derivatives of the non‐psychoactive cannabinoid, cannabidiol (CBD): HU‐446 and HU‐465 ((‐)‐ and [Read More]

 Page 1 of 118  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]